Company: DHR
Filing Date: 2025-03-26
Form Type: ARS
Source: 0000313616-25-000085
Chunk: 126

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: ARS
Chunk 126
---
 $ 23,875 Year ended December 31, 2023: Geographical region: North America(a) $ 2,454 $ 2,999 $ 4,508 $ 9,961 Western Europe 2,407 1,519 1,542 5,468 Other developed markets(b) 329 510 431 1,270 High-growth markets(c) 1,982 2,113 3,096 7,191 Total $ 7,172 $ 7,141 $ 9,577 $ 23,890 Revenue type: Recurring $ 5,897 $ 4,360 $ 8,425 $ 18,682 Nonrecurring 1,275 2,781 1,152 5,208 Total $ 7,172 $ 7,141 $ 9,577 $ 23,890 Year ended December 31, 2022: Geographical region: North America(a) $ 3,054 $ 3,154 $ 5,522 $ 11,730 Western Europe 2,645 1,377 1,837 5,859 Other developed markets(b) 358 506 481 1,345 High-growth markets(c) 2,701 1,999 3,009 7,709 Total $ 8,758 $ 7,036 $ 10,849 $ 26,643 Revenue type: Recurring $ 6,958 $ 4,220 $ 9,698 $ 20,876 Nonrecurring 1,800 2,816 1,151 5,767 Total $ 8,758 $ 7,036 $ 10,849 $ 26,643 (a) The Company defines North America as the United States and Canada. (b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets. (c) The Company defines high-growth markets as Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high- growth markets. 70

The Company’s products and services primarily consist of life sciences research, biopharmaceutical drug production and medical diagnostic products and services. The Company sells equipment to customers as well as consumables, software and services,